Nj State Employees Deferred Compensation Plan Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Nj State Employees Deferred Compensation Plan

  • $789 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 26, 2021
BUY
$64.07 - $91.75 $352,384 - $504,625
5,500 Added 36.67%
20,500 $1.4 Million
Q3 2019

Oct 18, 2019
BUY
$37.38 - $49.47 $336,420 - $445,230
9,000 Added 150.0%
15,000 $626,000
Q2 2019

Jul 24, 2019
BUY
$39.79 - $67.01 $238,740 - $402,060
6,000 New
6,000 $263,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Nj State Employees Deferred Compensation Plan Portfolio

Follow Nj State Employees Deferred Compensation Plan and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nj State Employees Deferred Compensation Plan, based on Form 13F filings with the SEC.

News

Stay updated on Nj State Employees Deferred Compensation Plan with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email